Get startedLog in
    Picture of Dare Bioscience logo

    DARE — Dare Bioscience News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Daré Bioscience Announces Ide Approval For A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study Of Ovaprene®

    Picture of Dare Bioscience logoDare Bioscience
    10/10/2022 13:11
    Oct 10 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES IDE APPROVAL FOR A SINGLE ARM,
OPEN-LABEL PIVOTAL CONTRACEPTIVE EFFICACY STUDY OF OVAPRENE®, AN
INVESTIGATIONAL HORMONE-FREE MONTHLY INTRAVAGINAL CONTRACEPTIVE

Source text for Eikon:  ID:nGNX8ZTyzJ 
Further company coverage:  DARE.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Dare Bioscience

    See all news